Hera Biolabs receives AAALAC Accreditation For Exceptional Animal Care
One of the most important parts of the entire drug [...]
Fine Need Aspirate Serial Tumor Sampling Services to Boost Your Xenograft Study Capabilities
Xenograft tumors from human cancer cell lines in immunocompromised mice are [...]
Validation of the SRG Rat for Human Tumor Studies Published in PLOS ONE
We are excited to announce that a validation study using [...]
Gene Editing With piggyBac: Creating A Curative Treatment For Beta-Thalassemia
Genetic engineering can soon lead to lifelong cures for diseases [...]
OncoRat® featured in Clinical Cancer Research for prostate cancer studies
Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems: A case [...]
The OncoRat® is the ideal host for patient-derived xenografts of ovarian cancer cells
Ovarian cancer is the most lethal gynecological cancer in the [...]
Evolution of the rat model
Rats have been favored for drug development studies because the [...]
H358 NSCLC xenografts in humanized rats: the ideal in vivo model for studying KRAS mutations
Lung adenocarcinomas, the major histological subtype of non-small cell lung [...]
Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research
Hera Biolabs, the University of Michigan, Case Western Reverse University [...]
Breakthroughs in gene editing allows for the creation of superior preclinical oncology models
Gene editing is getting a lot of attention in the [...]